| Issues |
Contents Summary |
Attachment |
| Issue 40 - November 2022 |
- Reminder on the Prescribing of Sodium Valproate safely in Women and Girls
- Notification of product name change: Carefine Insulin Pen Needles to Greenfine Insulin Pen Needles
- SPS Medicines Advice Service Information
- Medicines Optimisation MHRA Drug Safety Update – Oct 2022
- Direct oral anticoagulants (DOAC) infographic
- Product Discontinuation: FreeStyle Libre 1
- November Shortages
- Serious Shortage Protocols: Estraderm MX® 50mcg and 75mcg patches
- Discontinuation of Stemetil 5mg/5ml Syrup
- MHRA Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets
|
|
| Issue 41 - December 2022 |
- HSJ Awards Success
- OTC prescribing
- COPD inhaler guidance reminder
- Discontinuation of Stemetil 5mg/5ml Syrup
- Asthma and nebulisers
- All Ranitidine products – license suspended
- Shortages Summary December 2022
- MHRA Updates
- NICE News December 2022
|
Supply Shortage Alert |
| Issue 42 - January 2023 |
- Safety considerations with Metolazone preparations
- Over the counter medicines resources
- IT Support Ardens / EMIS
- MHRA Drug Safety Update
- Class 4 Medicines Defect Information: Galderma (U.K.) Limited, Epiduo 0.1% / 2.5% gel (45 g)
- Class 4 Medicines Defect Information: Albireo AB, Bylvay 1200 micrograms Hard Capsules, EL (23)A/01 Class 2 MHRA Recall – Dioctyl 100mg capsules
- Shortages
- Medicines Supply Notifications
- Serious Shortage Protocols
|
Supply Shortage Alert |
| Issue 43 - February 2023 |
- Best Practice Guidance for Care homes
- Ozempic prescribing
- Urgent Field Safety Notice: FreeStyle LibreLink App for Android and FreeStyle Libre 3 App for Android (all versions)
- Celebrating Advanced Practice Conference 17th March 2023
- Shortages
- Medicines Supply Notification: Senokot® syrup and Senokot® 12 Years Plus syrup (both containing 7.5mg/5ml sennosides)
- NICE news February 2023
|
|
| Issue 44 - March 2023 |
- Launch of the Kent and Medway ICB Medicines Optimisation Webpage
- Dexcom ONE transmitters on EMIS formulary
- Group A Strep (GAS) guidance update and impact on MOS sore throat audit.
- Inhaler Spacer Device Prescribing
- Salbutamol Prescribing
- MDI to DPI Switch
- MHRA Metolazone Drug Safety Update
- Clinical Fellow Scheme Application Information
- NICE CG181 Update
- KMPT Video Guides for Patients on Medicines Information
- Medicines Optimisation MHRA Drug Safety Update – Jan and Feb 2023
- MHRA Class 4 Defect Information- Venlafaxine 150mg,225mg and 300mg
- Shortages Summary March 2023
|
Supply Shortage Alert |
| Issue 45 - April 2023 |
- Hormone Replacement Therapy (HRT) Prepayment Certificate (PPC)
- Chronic Pain Resources
- Non-Medical Prescribing and Controlled Drugs
- Reminder on Oral Hygiene Prescribing
- Antimicrobial Prescribing Survey
- Genomics Webinar: Aminoglycosides Pharmacogenetic Testing
- West Kent PCN Pharmacy Support Network Learning Session
- Medicines Optimisation MHRA Drug Safety Update – March 2023
- NICE News April 2023
- Shortages Summary April 2023
- MHRA - Class 4 Medicines Defect Information: Sandoz Limited, Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension, EL (23)A/14
|
Supply Shortage Alert |
| Issue 46 - May 2023 |
- New Back-up (delayed) Antibiotic Prescribing Guidance
- New C.difficile Prescribing Guidance
- Hormone Replacement Therapy (HRT) Prescribing Guidelines
- Sharing Learning from a Serious Incident
- Potential Under-recognised Risk of Harm from the Use of Propranolol in Certain Patient Cohorts
- MHRA Drug Safety Updates
- AQUACEL Ag+ Upgrade
- Shortage information
|
Supply Shortage Alert |
| Issue 47 - June 2023 |
- Inclisiran (Leqvio®) update on QOF and funding
- Links to Formulary Websites and Document Sharing Platforms
- Prescribing in Pain Symposium
- Opioids – Safer Prescribing and Preferred Cost-effective Brands. Information for General Practice
- Free training for community pharmacists and practice base pharmacists
- Medicine Supply Notification – Shortage of Oxcarbazepine (Trileptal®) 300mg and 600mg tablets
- Medicine Supply Notification – Shortage of Glucagon 1mg powder for injection kit (GlucaGen®) (Novo Nordisk Ltd)
- Medicine Supply Notification – Shortage of Tresiba® (insulin degludec) FlexTouch 100units/ml solution for injection 3ml pre-filled pens (Novo Nordisk Ltd)
- MHRA Drug Safety Update May 2023
- Shortages Summary
- NICE News
|
Supply Shortage Alert |
| Issue 48 - July 2023 |
- Kent and Medway position statement on Inclisiran (Leqvio®)
- MHRA Drug Safety Update June 2023
- Medicine Recalls
- GLP-1 Receptor Agonist Shortage
- Gluten Free Prescribing in Kent and Medway
- NEWT guidelines subscription renewal
- Missed Savings Opportunity
- EOL medication
- Shortages Summary
|
Supply Shortage Alert |
| Issue 49 - August 2023 |
- Reducing the cost of OTC Prescriptions and freeing up Practice and Pharmacy time
- Vitamin B12 Prescribing in Kent and Medway
- Care Homes Best Practice Guidance
- Asthma training/engagement sessions
- Webinar on Lipids Management
- National Patient Safety Alert (NatPSA) – Potent Synthetic Opioids implicated in Heroin overdoses and deaths
- Adrenaline auto-injectors (AAIs) MHRA guidance
- MHRA Drug Safety Update August 2023
- Medicine Recalls
- Shortages Summary
- NICE News August 2023
|
Supply Shortage Alert |
| Issue 50 - September 2023 |
- Hypomagnesaemia in Adults – New Primary Care Guidance
- New Oral Nutritional Supplement (ONS) Guidelines in Kent and Medway
- Kent and Medway Asthma Guidance
- Triptorelin Formulary Addition
- New guidelines and formulary changes for insulin pen needles, meters, test strips and lancets
- High strength insulin
- National Patient Safety Alert – Shortage of GLP-1 Receptor Agonists
- MHRA Drug Safety Update
- Shortages
- ADHD Medication Shortages
- The 16th Royal Marsden Opioid, Cannabinoid & Gabapentinoid Conference
- Using Skin Barriers with Sensors of Glucose Monitoring Systems
|
Supply Shortage Alert |
| Issue 51 - October 2023 |
- Update October 2023: Paediatric Asthma and Nebulisers
- Best Practice Guidance (BPG) for Care Homes
- Substance Misuse - Naloxone
- The Role of Inclisiran in Lipid Management
- Recommendations on the national supply disruption to ADHD medication
- Valproate containing products – October 2023 Drug Tariff update
- Pharmacists Epilepsy Education Group (PEEG)
- Antimicrobial Prescribing and Stewardship (APS) Competency Framework
- Serious Shortage Protocols for Clarithromycin
- MHRA Drug Safety Update – September 2023
- Shortages Summary
- NICE News – October 2023
|
Supply Shortage Alert |
| Issue 52 - November 2023 |
- Kent & Medway Medicines Sustainability Re-Hale Project
- Direct Oral Anticoagulants (DOACs) – A Change to Improve Patient Safety
- Emollients and fire safety
- New Melatonin Guidelines in Kent and Medway
- Gastro-intestinal Anti-spasmodic Prescribing
- New Position Statement: Safe Prescribing of Injectable Medicines in Primary Care
- Addition of Actimorph orodispersible morphine to formularies and new Morphine Sulfate Liquid Guidance
- Addition of Methenamine Hippurate to the Kent and Medway Formulary
- Nitrofurantoin MHRA Drug Safety Update – New Supporting guidance for patients and prescribers
- Wegovy and risks of inadvertent prescribing and dispensing of injectable semaglutide
- Kent and Medway guidance on Emollient Prescribing
- MHRA Drug Safety Update
- Shortages Summary
|
Supply Shortage Alert |